Vanessa E. Gray

Multiplex assessment of protein variant abundance by massively parallel sequencing

Kenneth A. Matreyek, Lea M. Starita, Jason J. Stephany et al. · Nature Genetics · 2018 · 522 citations · Full text

Life Sciences, Genetics, Molecular Biology +11

Quantitative Missense Variant Effect Prediction Using Large-Scale Mutagenesis Data

Vanessa E. Gray, Ronald J. Hause, Jens Luebeck et al. · Cell Systems · 2017 · 252 citations · Full text

Life Sciences, Bioinformatics, Genetics +8

Analysis of Large-Scale Mutagenesis Data To Assess the Impact of Single Amino Acid Substitutions

Vanessa E. Gray, Ronald J. Hause, Douglas M. Fowler · Genetics · 2017 · 164 citations · Full text

Life Sciences, Molecular Biology, Molecular Evolution +9

A randomized phase 2 trial of azacitidine with or without durvalumab as first-line therapy for older patients with AML

Amer M. Zeidan, Isaac W. Boss, C.L. Beach et al. · Blood Advances · 2021 · 82 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Efficacy and Safety of Azacitidine (AZA) in Combination with the Anti-PD-L1 Durvalumab (durva) for the Front-Line Treatment of Older Patients (pts) with Acute Myeloid Leukemia (AML) Who Are Unfit for Intensive Chemotherapy (IC) and Pts with Higher-Risk Myelodysplastic Syndromes (HR-MDS): Results from a Large, International, Randomized Phase 2 Study

Amer M. Zeidan, James D. Cavenagh, Maria Teresa Voso et al. · Blood · 2019 · 78 citations

Medicine, Oncology, Pharmacotherapy +17